Indian companies making Covid-19 vaccine upset over lack of norms and infrastructure
Posted by
www.biotecnika.org
India is staring at the risk of losing its competitive advantage in
vaccine manufacturing to other countries, Biological E chairperson
said, even as she also complained about lack of enough clinical trial
sites and infrastructure in the country.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-companies-making-covid-19-vaccine-upset-over-lack-of-norms-and-infrastructure/articleshow/77359274.cms
Subscribe to:
Post Comments (Atom)
Post a Comment